Table 2. Comparison of findings.

Variable	Liraglutide (4)	Other TZD’s (5)	Vitamin E (5)	OCA (5)	Pentoxifylline (5)
Improved fibrosis				X	X
No worsening fibrosis	X
Decrease BMI	X	Increase BMI		X	X
NAFL score improvement	No
Hepatocyte ballooning score improvement	X	X	X	X
Lobular inflammation score improvement		X		X	X
Steatosis improvement	X	X		X	X
Resolution of non-alcoholic steatohepatitis post biopsy	X
Possible medication issues i.e., toxicities	GI side effects	Weight gain, cardiovascular	Prostate issues, increased CV mortality

X, the finding is present in listed variable, for indicated medication. TZD, thiazolidinediones; OCA, obeticholic acid.